Related Experiment Videos
Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2
1Molecular Medicine, Northwest Hospital, Seattle, WA 98125, USA. rphuang@nwlink.com
Abstract:
Previously, we showed that the transcription factor Egr-1 suppressed the proliferation of v-sis transformed NIH3T3 cells and also a number of human tumor cells. Here, we investigate the possible mechanisms responsible for this function. We show that transfected Egr-1 in human fibrosarcoma cells HT1080 leads to down-regulation of Bcl-2. Transient CAT transfection assays reveal that expression of Egr-1 suppresses Bcl-2 promoter activity in a dose-dependent manner. Furthermore, overexpression of Bcl-2 in Egr-1-expressing HT1080 cells enhanced cell proliferation in monolayer culture and increased anchorage-independent growth. Our results suggest that suppression of tumor cell proliferation by Egr-1 may be at least partially mediated through the down-regulation of Bcl-2.
Insights
The transcription factor Egr-1 inhibits tumor cell growth by reducing Bcl-2 levels. This study reveals Egr-1
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The transcription factor Egr-1 has been previously shown to suppress the proliferation of various cancer cells.
- Understanding the mechanisms behind Egr-1's tumor-suppressive function is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the molecular mechanisms by which Egr-1 suppresses tumor cell proliferation.
- To determine the role of Bcl-2 in Egr-1-mediated growth inhibition.
Main Methods:
- Transfection of human fibrosarcoma cells (HT1080) with Egr-1.
- Analysis of Bcl-2 expression levels and promoter activity.
- Cell proliferation assays in monolayer and soft agar.
Main Results:
- Egr-1 transfection led to the down-regulation of Bcl-2 in HT1080 cells.
- Egr-1 suppressed Bcl-2 promoter activity in a dose-dependent manner.
- Overexpression of Bcl-2 counteracted the anti-proliferative effects of Egr-1, enhancing cell growth and anchorage-independent growth.
Conclusions:
- Egr-1-mediated suppression of tumor cell proliferation is, at least partially, achieved through the down-regulation of the anti-apoptotic protein Bcl-2.
- Targeting the Egr-1/Bcl-2 pathway may represent a therapeutic strategy for certain cancers.